The Strategic Advisory Group of Experts on Immunization (SAGE) will hold a virtual press conference to brief the journalists of the outcome of their biannual meeting that took place from 5 to 7 October.
During the meeting, SAGE discussed critical topics relating to immunization globally. Agenda items included:
- Impact of the COVID-19 pandemic on immunization activities
- Updated evidence on efficacy, effectiveness and safety of rotavirus vaccines
- Polio eradication and novel oral polio vaccine type 2 (nOPV2) development
- COVID-19 vaccine priority populations
- Pneumococcal Vaccines: considerations for use in older adults and use in outbreak settings
WHEN: Friday, 9 October at 12:30 CEST (Central European Summer Time)
Speakers:
- Dr Alejandro Cravioto, Chair, Strategic Advisory Group of Experts (SAGE) on Immunization
- Dr Joachim Hombach, Executive Secretary SAGE, WHO
- Dr Kate O’Brien, Director, Department of Immunization, Vaccines and Biologicals, WHO
- Simona Zipursky, co-lead of the Global Polio Eradication Initiative nOPV2 Working Group, WHO
Dial in details: https://who-e.zoom.us/j/92112819636 Password: SAGE2020
Phone:
- Webinar ID: 921 1281 9636
- Numeric passcode for phone access: 04422210
- International numbers available: https://who-e.zoom.us/u/afNZLP63L
Audio recording of the press conference will be made available.
What is SAGE?
The Strategic Advisory Group of Experts (SAGE) on Immunization is the principal advisory group to WHO for vaccines and immunization. It is charged with advising WHO on overall global policies and strategies, ranging from vaccines and technology, research and development, to delivery of immunization and its linkages with other health interventions. SAGE is concerned not just with childhood vaccines and immunization, but all vaccine-preventable diseases.
For the meeting agenda and more information on SAGE, visit: https://www.who.int/immunization/policy/sage/en/
